Overview
Short Course: October 18
Meeting: October 19-20
The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safey considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe. This meeting presents three tracks: Regulatory, Clinical, and Pharmacovigilance (NEW). Our new pharmacovigilance track, previously its own meeting, broadens the scope of this meeting and will provide additional insights, education and knowledge sharing for our attendees to discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
Featured
Who should attend?
Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:
- Clinical Data Management/eClinical
- Comparative Effectiveness/Health Technology Assessment
- Clinical Safety/Pharmacovigilance
- Clinical Research
- Document Management/eSubmissions
- Medical Communications
- Outsourcing
- Project Management
- Public Policy/Law/Corporate Compliance
- Quality Assurance Control
- Regulatory Affairs
- Research and Development
- Statistics
Program Committee
-
Marcia Bailey, BSN, MHS, RN • Safety Evaluation and Risk Management Scientific Director
GSK, Canada -
Marilyne Chamoun, MSc • Senior Scientific Evaluator, Marketed Pharmaceuticals Bureau
Health Canada, Canada -
Mandy Collier • Director, Health Products and Food Branch
Health Canada, Canada -
Caroline Croteau, PhD, RPh • Country Safety Lead
Pfizer Canada Inc, Canada -
Deborah Danoff, MD, FRCPC • Medical Evaluator
Health Canada, Canada -
Samar Darwish, MBA, MSc • Director, Drug Regulatory Affairs
Boehringer Ingelheim, Canada -
Patrick Fandja, MBA, MS • Director, Bureau of Biologics, Radiopharmaceuticals and Self-care products
Health Canada, Canada -
Fiona M Frappier, PhD • Senior Policy Analyst
Health Canada, Canada -
Agnes Jankowicz, MS • Vice President, Pharmacovigilance
Veristat, Canada -
Yatika Kohli, PhD, MBA • Chief Regulatory and Strategy Officer
NoNO Inc, Canada -
Judith Mergl, MSc • Director, Regulatory Affairs and Operational Services
AbbVie Corporation, Canada -
Kristin Willemsen, MS • Vice President, Scientific & Regulatory Affairs
Food, Health & Consumer Products of Canada, Canada
Contact us
Registration Questions?
Additional Information
Sign up to be notified when registration opens for the DIA 2022 Events